Page last updated: 2024-11-07

cyanidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyanidin: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyanidin cation : An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID128861
CHEMBL ID404515
CHEBI ID27843
SCHEMBL ID20799
MeSH IDM0067674

Synonyms (37)

Synonym
S00118
3,3',4,5,7-pentahydroxyflavylium chloride
cyanidin cation
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenium
3,5,7,3',4'-pentahydroxyflavylium
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromenylium
13306-05-3
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyrylium
CHEBI:27843 ,
2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol
3,3',4',5,7-pentahydroxyflavyliumchlorid
chlorure de 3,3',4',5,7-pentahydroxyflavylium
cyanidin
cyanidol
C05905
inchi=1/c15h10o6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-6h,(h4-,16,17,18,19,20)/p+
1-benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-
cyanidin ion
2-(3,4-dihydroxyphenyl) chromenylium-3,5,7-triol
flavylium, 3,3',4',5,7-pentahydroxy-
LMPK12010002
3,3'',4'',5,7-pentahydroxyflavylium
bdbm50241503
3,5,7,3'''',4''''-pentahydroxyflavylium
cyanidin(1+)
CHEMBL404515 ,
VEVZSMAEJFVWIL-UHFFFAOYSA-O
7732zhu564 ,
unii-7732zhu564
niosh/lk9820000
flavylium, 3,3',4',5,7-pentahydroxy-, acid anion
benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, acid anion
LK98200000
3,3',4',5,7-pentahydroxyflavylium acid anion
SCHEMBL20799
DTXSID10157933
Q417606

Research Excerpts

Overview

Cyanidin is an anthocyanin widely distributed in food diet with novel antioxidant activity. Cyanidin likely acts as a physiological PPARα agonist. It reduces hepatic lipid concentrations by rewiring genes involved in lipid metabolic pathways.

ExcerptReferenceRelevance
"Cyanidin is a natural anthocyanidin present in fruits and vegetables with anti-diabetic properties including stimulation of insulin secretion. "( Cyanidin Stimulates Insulin Secretion and Pancreatic β-Cell Gene Expression through Activation of l-type Voltage-Dependent Ca
Adisakwattana, S; Cheng, H; Elazab, ST; Hsu, WH; Suantawee, T; Yao, S, 2017
)
3.34
"Cyanidin is an anthocyanin found in many foods. "( Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
Hao, Y; Li, L; Liu, Q; Liu, X; Luo, J; Luo, X; Sun, B; Wang, Q; Wu, Y; Xu, J; Yang, Z; Zhang, D; Zhou, T, 2018
)
3.37
"Cyanidin is an anthocyanidin extracted from a variety of fruits and vegetables. "( Cyanidin Protects SH-SY5Y Human Neuroblastoma Cells from 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity.
Chen, J; Jiang, J; Sun, J; Zhou, J, 2018
)
3.37
"Cyanidin is an anthocyanin widely distributed in food diet with novel antioxidant activity."( Dual Effect of Cyanidin on RANKL-Induced Differentiation and Fusion of Osteoclasts.
Cao, Z; Dong, S; Dou, C; Jiang, H; Kang, F; Li, J; Xiang, J; Xu, J; Yang, B; Yang, X, 2016
)
1.51
"Cyanidin likely acts as a physiological PPARα agonist and potentially for PPARβ/δ and γ, and reduces hepatic lipid concentrations by rewiring the expression of genes involved in lipid metabolic pathways."( Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid.
Chang, HI; Hoang, MH; Hwang, KY; Jia, Y; Jun, HJ; Kim, HS; Kim, JY; Kim, SJ; Lee, JH; Lee, SJ; Um, SJ, 2013
)
2.55
"Cyanidin is an anthocyanin widely distributed in food diet with novel antioxidant activity. "( Cyanidin reverses cisplatin-induced apoptosis in HK-2 proximal tubular cells through inhibition of ROS-mediated DNA damage and modulation of the ERK and AKT pathways.
Chen, T; Choi, MY; Gao, S; Liang, Y; Wong, YS; Xue, J, 2013
)
3.28

Effects

Anthocyanidins have been extensively investigated due to their antioxidative, antidiabetic and anti-inflammatory effects. cyanidin has been designated for a better comparison and understanding of the potential neuroprotection of juices obtained from two Vaccinium species.

ExcerptReferenceRelevance
"As cyanidin derivatives have been identified as one of the most representative polyphenols in berry juices, cyanidin has been designated for a better comparison and understanding of the potential neuroprotection of juices obtained from two Vaccinium species."( Regulation of redox status in neuronal SH-SY5Y cells by blueberry (Vaccinium myrtillus L.) juice, cranberry (Vaccinium macrocarpon A.) juice and cyanidin.
Cásedas, G; Gómez-Serranillos, MP; González-Burgos, E; López, V; Smith, C, 2018
)
1.2
"Anthocyanidins have been extensively investigated due to their antioxidative, antidiabetic and anti-inflammatory effects."( Effects of malvidin, cyanidin and delphinidin on human adipose mesenchymal stem cell differentiation into adipocytes, chondrocytes and osteocytes.
Jekabsons, K; Klavins, M; Muceniece, R; Riekstina, U; Saulite, L, 2019
)
1.29

Treatment

ExcerptReferenceRelevance
"Cyanidin treatment reduced IL-17A mediated reprogramming of AA-FLS cells to overexpress IL-17RA."( Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis.
Ganesan, R; Rasool, M; Samarpita, S, 2020
)
2.72

Toxicity

ExcerptReferenceRelevance
"Functional foods need to be assessed for beneficial effects to support claims, but also for toxic effects."( Initial in vitro toxicity testing of functional foods rich in catechins and anthocyanins in human cells.
Böhm, V; Glei, M; Matuschek, M; Persin, C; Pool-Zobel, BL; Steiner, C,
)
0.13
"Cisplatin-based chemotherapy in clinic is severely limited by its adverse effect, including neurotoxicity."( Attenuation of Cisplatin-Induced Neurotoxicity by Cyanidin, a Natural Inhibitor of ROS-Mediated Apoptosis in PC12 Cells.
Fan, CD; Fang, J; Fu, XY; Hou, YJ; Li, DW; Mao, LL; Sun, BL; Sun, JY; Wang, K; Yang, MF; Yuan, H; Zhang, S; Zhang, ZY; Zhu, MJ, 2015
)
0.67
" Here, we show that they freely accumulate in dopaminergic (MN9D and SH-SY5Y) as well as in liver (HepG2) cells, but are specifically and highly toxic to dopaminergic cells with IC50s in the range of 50-100 nM, demonstrating that they are about 1000-fold more toxic than MPP(+) under similar experimental conditions."( 2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.
Kadigamuwa, CC; Le, VQ; Wimalasena, K, 2015
)
0.42

Bioavailability

Cyanidin 3-O-glucopyranoside (Cy-3G) has poor systemic bioavailability. Review summarized recent data on the anticancer properties of cyanidings.

ExcerptReferenceRelevance
" However, one consistent result of these studies is that the systemic bioavailability of anthocyanins, including cyanidin 3-O-glucopyranoside (Cy-3G), is very poor."( Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells.
Angeloni, C; Cantelli-Forti, G; Hrelia, P; Hrelia, S; Marchesi, A; Morroni, F; Tarozzi, A, 2007
)
0.55
" It is concluded that although Cy and Cyg bioavailability is low, further investigations are necessary because some important metabolites may still not have been identified."( Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides.
Felgines, C; Fogliano, V; Galvano, F; La Fauci, L; Vanella, L; Vitaglione, P, 2007
)
0.56
"The aim of this study was to investigate the bioavailability of anthocyanins from chokeberry juice with a dietary-relevant dose of anthocyanins."( Bioavailability of cyanidin glycosides from natural chokeberry (Aronia melanocarpa) juice with dietary-relevant dose of anthocyanins in humans.
Piskula, MK; Romaszko, E; Wiczkowski, W, 2010
)
0.69
" Our results suggest that polyphenolic compounds might be potential structural bases and source to find and project nature-based, safe, orally bioavailable direct thrombin inhibitors."( Thrombin inhibitory activity of some polyphenolic compounds.
Bijak, M; Krotkiewski, H; Nowak, P; Pawlaczyk, I; Ponczek, M; Saluk, J; Wachowicz, B; Ziewiecki, R, 2014
)
0.4
" The present comprehensive review summarized recent data on the anticancer properties of cyanidings along with natural sources, phytochemical data, traditional medical applications, molecular mechanisms and recent nanostrategies to increase the bioavailability and anticancer effects of cyanidins."( An updated overview of cyanidins for chemoprevention and cancer therapy.
Aldahish, AA; Calina, D; Cho, WC; Eid, AH; Giordo, R; Gürer, ES; Habtemariam, S; Kennedy, JF; Modu, B; Nasrallah, GK; Pintus, G; Posadino, AM; Ramli, I; Razis, AFA; Sharifi-Rad, J; Wehbe, Z; Zayed, H, 2023
)
1.44

Dosage Studied

Cyanidin and delphinidin were identified as natural product inhibitors. Lower dosage of cyanidin has a promoting effect on osteoclastogenesis while higher dosage has an inhibitory effect. Rats were randomly divided into normal group (NM), adjuvant arthritis group (AA) and three cyanidins-treated groups.

ExcerptRelevanceReference
" Rats were randomly divided into normal group (NM), adjuvant arthritis group (AA) and three cyanidin-treated groups in high dosage (HA), middle dosage (MA), and low dosage (LA)."( [Antioxidant and anti-inflammatory effects of cyanidin from cherries on rat adjuvant-induced arthritis].
He, YH; Jia, HW; Li, XM; Lu, AP; Lu, C; Tong, Y; Wang, YS; Xiao, C; Zhao, HY; Zhao, LH; Zhou, J, 2005
)
0.81
" The implementation of this assay to the screening of a highly diverse academic chemical library of 14,300 molecules yielded, after secondary assays and generation of dose-response curves, the identification of two natural product inhibitors, cyanidin and delphinidin."( Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
Haiech, J; Hibert, M; Kellenberger, E; Kuhn, I; Lobstein, A; Muller-Steffner, H; Rognan, D; Said-Hassane, F; Schuber, F; Villa, P, 2010
)
0.54
" With delphinidin and malvidin, a biphasic dose-response was observed for protection against cyclophosphamide."( Protective effects of common anthocyanidins against genotoxic damage induced by chemotherapeutic drugs in mice.
Abraham, SK; Khandelwal, N, 2014
)
0.68
" Lower dosage of cyanidin (< 1 µg/ml) has a promoting effect on osteoclastogenesis while higher dosage of cyanidin (> 10 µg/ml) has an inhibitory effect."( Dual Effect of Cyanidin on RANKL-Induced Differentiation and Fusion of Osteoclasts.
Cao, Z; Dong, S; Dou, C; Jiang, H; Kang, F; Li, J; Xiang, J; Xu, J; Yang, B; Yang, X, 2016
)
1.13
" There was no significant difference between preventive and long-term treatment groups at the same dosage of C3G."( Cyanidin-3-O-glucoside, cyanidin, and oxidation products of cyanidin protect neuronal function through alleviating inflammation and oxidative damage.
Li, Z; Liu, Q; Yang, L; Zhu, Z, 2022
)
2.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
5-hydroxyanthocyanidinAny anthocyanidin cation that carries a hydroxy substituent at position 5.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Representative anthocyanin biosynthetic pathway87
Flavonoid pathway06
AtMetExpress overview0109
Anthocyanin biosynthesis (pelargonidin 3-O-glucoside, cyanidin 3-O-glucoside)013

Protein Targets (7)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ProthrombinHomo sapiens (human)IC50 (µMol)0.25000.00000.710710.0000AID768929
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)90,000.00000.00021.557410.0000AID378690; AID403341
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)IC50 (µMol)21.80006.00006.83338.2000AID603318
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)60,000.00000.00010.995010.0000AID378691; AID403340
Death-associated protein kinase 1Homo sapiens (human)IC50 (µMol)150.00000.00052.284510.0000AID1247840
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ProthrombinHomo sapiens (human)Kd0.00780.00000.01010.0387AID768894
Oxysterols receptor LXR-betaHomo sapiens (human)EC50 (µMol)125.20000.00010.40077.3000AID758939
Oxysterols receptor LXR-betaHomo sapiens (human)Kd73.20000.10300.10300.1030AID758944
Oxysterols receptor LXR-alphaHomo sapiens (human)EC50 (µMol)3.50000.00010.63026.7100AID758940
Oxysterols receptor LXR-alphaHomo sapiens (human)Kd2.20000.09243.12566.9700AID758943
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (168)

Processvia Protein(s)Taxonomy
positive regulation of protein phosphorylationProthrombinHomo sapiens (human)
proteolysisProthrombinHomo sapiens (human)
acute-phase responseProthrombinHomo sapiens (human)
cell surface receptor signaling pathwayProthrombinHomo sapiens (human)
G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell population proliferationProthrombinHomo sapiens (human)
regulation of cell shapeProthrombinHomo sapiens (human)
response to woundingProthrombinHomo sapiens (human)
negative regulation of platelet activationProthrombinHomo sapiens (human)
platelet activationProthrombinHomo sapiens (human)
regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell growthProthrombinHomo sapiens (human)
positive regulation of insulin secretionProthrombinHomo sapiens (human)
positive regulation of collagen biosynthetic processProthrombinHomo sapiens (human)
fibrinolysisProthrombinHomo sapiens (human)
negative regulation of proteolysisProthrombinHomo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATProthrombinHomo sapiens (human)
negative regulation of astrocyte differentiationProthrombinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolProthrombinHomo sapiens (human)
regulation of cytosolic calcium ion concentrationProthrombinHomo sapiens (human)
cytolysis by host of symbiont cellsProthrombinHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProthrombinHomo sapiens (human)
negative regulation of fibrinolysisProthrombinHomo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptideProthrombinHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumProthrombinHomo sapiens (human)
positive regulation of lipid kinase activityProthrombinHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responseProthrombinHomo sapiens (human)
positive regulation of protein localization to nucleusProthrombinHomo sapiens (human)
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
ligand-gated ion channel signaling pathwayProthrombinHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processProthrombinHomo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
response to hypoxiaADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
signal transductionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
female pregnancyADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to xenobiotic stimulusADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of neuron projection developmentADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
artery smooth muscle contractionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
NAD metabolic processADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of cell growthADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of B cell proliferationADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of insulin secretionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to estradiolADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to retinoic acidADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to progesteroneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to hydroperoxideADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
B cell proliferationADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of apoptotic processADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of bone resorptionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of vasoconstrictionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
B cell receptor signaling pathwayADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
long-term synaptic depressionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to interleukin-1ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
apoptotic signaling pathwayADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
defense response to tumor cellDeath-associated protein kinase 1Homo sapiens (human)
regulation of response to tumor cellDeath-associated protein kinase 1Homo sapiens (human)
protein phosphorylationDeath-associated protein kinase 1Homo sapiens (human)
apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsDeath-associated protein kinase 1Homo sapiens (human)
regulation of autophagyDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of autophagyDeath-associated protein kinase 1Homo sapiens (human)
negative regulation of translationDeath-associated protein kinase 1Homo sapiens (human)
intracellular signal transductionDeath-associated protein kinase 1Homo sapiens (human)
regulation of apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
negative regulation of apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
protein autophosphorylationDeath-associated protein kinase 1Homo sapiens (human)
cellular response to type II interferonDeath-associated protein kinase 1Homo sapiens (human)
cellular response to hydroperoxideDeath-associated protein kinase 1Homo sapiens (human)
apoptotic signaling pathwayDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of autophagic cell deathDeath-associated protein kinase 1Homo sapiens (human)
regulation of NMDA receptor activityDeath-associated protein kinase 1Homo sapiens (human)
hormone-mediated signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of triglyceride biosynthetic processOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of cholesterol effluxOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of lipid storageOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of cholesterol storageOxysterols receptor LXR-betaHomo sapiens (human)
intracellular receptor signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of lipid transportOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of cholesterol transportOxysterols receptor LXR-betaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingOxysterols receptor LXR-betaHomo sapiens (human)
cholesterol homeostasisOxysterols receptor LXR-betaHomo sapiens (human)
mRNA transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of fatty acid biosynthetic processOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of proteolysisOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of DNA-templated transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of pinocytosisOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of lipoprotein lipase activityOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of protein metabolic processOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of high-density lipoprotein particle assemblyOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of pancreatic juice secretionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of secretion of lysosomal enzymesOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of cold-induced thermogenesisOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of miRNA transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressOxysterols receptor LXR-betaHomo sapiens (human)
cell differentiationOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
hormone-mediated signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of triglyceride biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of cholesterol effluxOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of cholesterol storageOxysterols receptor LXR-alphaHomo sapiens (human)
intracellular receptor signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of lipid transportOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of cholesterol transportOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of transporter activityOxysterols receptor LXR-alphaHomo sapiens (human)
response to progesteroneOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of toll-like receptor 4 signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingOxysterols receptor LXR-alphaHomo sapiens (human)
cholesterol homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
regulation of circadian rhythmOxysterols receptor LXR-alphaHomo sapiens (human)
mRNA transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of macrophage activationOxysterols receptor LXR-alphaHomo sapiens (human)
apoptotic cell clearanceOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of fatty acid biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of proteolysisOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of pinocytosisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of inflammatory responseOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of lipoprotein lipase activityOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of protein metabolic processOxysterols receptor LXR-alphaHomo sapiens (human)
lipid homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
sterol homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
triglyceride homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
cellular response to lipopolysaccharideOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of pancreatic juice secretionOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of secretion of lysosomal enzymesOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of cold-induced thermogenesisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressOxysterols receptor LXR-alphaHomo sapiens (human)
cell differentiationOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (41)

Processvia Protein(s)Taxonomy
lipopolysaccharide bindingProthrombinHomo sapiens (human)
serine-type endopeptidase activityProthrombinHomo sapiens (human)
signaling receptor bindingProthrombinHomo sapiens (human)
calcium ion bindingProthrombinHomo sapiens (human)
protein bindingProthrombinHomo sapiens (human)
growth factor activityProthrombinHomo sapiens (human)
heparin bindingProthrombinHomo sapiens (human)
thrombospondin receptor activityProthrombinHomo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
NAD+ nucleosidase activityADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
transferase activityADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
identical protein bindingADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
NAD+ nucleotidase, cyclic ADP-ribose generatingADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
phosphorus-oxygen lyase activityADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
protein kinase activityDeath-associated protein kinase 1Homo sapiens (human)
protein serine/threonine kinase activityDeath-associated protein kinase 1Homo sapiens (human)
calmodulin-dependent protein kinase activityDeath-associated protein kinase 1Homo sapiens (human)
protein bindingDeath-associated protein kinase 1Homo sapiens (human)
calmodulin bindingDeath-associated protein kinase 1Homo sapiens (human)
ATP bindingDeath-associated protein kinase 1Homo sapiens (human)
GTP bindingDeath-associated protein kinase 1Homo sapiens (human)
syntaxin-1 bindingDeath-associated protein kinase 1Homo sapiens (human)
identical protein bindingDeath-associated protein kinase 1Homo sapiens (human)
protein serine kinase activityDeath-associated protein kinase 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificOxysterols receptor LXR-betaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificOxysterols receptor LXR-betaHomo sapiens (human)
DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
protein bindingOxysterols receptor LXR-betaHomo sapiens (human)
zinc ion bindingOxysterols receptor LXR-betaHomo sapiens (human)
chromatin DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
apolipoprotein A-I receptor bindingOxysterols receptor LXR-betaHomo sapiens (human)
nuclear retinoid X receptor bindingOxysterols receptor LXR-betaHomo sapiens (human)
ATPase bindingOxysterols receptor LXR-betaHomo sapiens (human)
nuclear receptor activityOxysterols receptor LXR-betaHomo sapiens (human)
transcription cis-regulatory region bindingOxysterols receptor LXR-alphaHomo sapiens (human)
transcription cis-regulatory region bindingOxysterols receptor LXR-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificOxysterols receptor LXR-alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificOxysterols receptor LXR-alphaHomo sapiens (human)
DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
nuclear receptor activityOxysterols receptor LXR-alphaHomo sapiens (human)
protein bindingOxysterols receptor LXR-alphaHomo sapiens (human)
zinc ion bindingOxysterols receptor LXR-alphaHomo sapiens (human)
cholesterol bindingOxysterols receptor LXR-alphaHomo sapiens (human)
chromatin DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
sterol response element bindingOxysterols receptor LXR-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (34)

Processvia Protein(s)Taxonomy
external side of plasma membraneProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular regionProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
endoplasmic reticulum lumenProthrombinHomo sapiens (human)
Golgi lumenProthrombinHomo sapiens (human)
plasma membraneProthrombinHomo sapiens (human)
extracellular exosomeProthrombinHomo sapiens (human)
blood microparticleProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
plasma membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
cell surfaceADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
basolateral plasma membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
nuclear membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
extracellular exosomeADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
plasma membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmDeath-associated protein kinase 1Homo sapiens (human)
plasma membraneDeath-associated protein kinase 1Homo sapiens (human)
postsynaptic densityDeath-associated protein kinase 1Homo sapiens (human)
actin cytoskeletonDeath-associated protein kinase 1Homo sapiens (human)
glutamatergic synapseDeath-associated protein kinase 1Homo sapiens (human)
DAPK1-calmodulin complexDeath-associated protein kinase 1Homo sapiens (human)
cytoplasmDeath-associated protein kinase 1Homo sapiens (human)
nucleusDeath-associated protein kinase 1Homo sapiens (human)
nucleusOxysterols receptor LXR-betaHomo sapiens (human)
nucleoplasmOxysterols receptor LXR-betaHomo sapiens (human)
cytoplasmOxysterols receptor LXR-betaHomo sapiens (human)
cytosolOxysterols receptor LXR-betaHomo sapiens (human)
RNA polymerase II transcription regulator complexOxysterols receptor LXR-betaHomo sapiens (human)
chromatinOxysterols receptor LXR-betaHomo sapiens (human)
nucleusOxysterols receptor LXR-betaHomo sapiens (human)
nucleusOxysterols receptor LXR-alphaHomo sapiens (human)
nucleoplasmOxysterols receptor LXR-alphaHomo sapiens (human)
cytoplasmOxysterols receptor LXR-alphaHomo sapiens (human)
cytosolOxysterols receptor LXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexOxysterols receptor LXR-alphaHomo sapiens (human)
chromatinOxysterols receptor LXR-alphaHomo sapiens (human)
receptor complexOxysterols receptor LXR-alphaHomo sapiens (human)
nucleusOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (55)

Assay IDTitleYearJournalArticle
AID768927Inhibition of human thrombin assessed as inhibition of fibrinogen polymerization preincubated for 10 mins followed by fibrionogen addition measured for 20 mins2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID537629Selectivity ratio of IC50 for human recombinant CD38 to IC50 for Schistosoma mansoni recombinant NAD+ glycohydrolase2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID378692Ratio of IC50 for human PGHS1 to IC50 for human PGHS21999Journal of natural products, Feb, Volume: 62, Issue:2
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries.
AID768892Competitive inhibition of human thrombin using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by Lineweaver-Burk plot analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID768929Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758937Agonist activity at LXRbeta in human HepG2 cells assessed as LXRbeta transcription at 50 to 100 uM after 24 hrs by RT-qPCR analysis2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768894Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758944Binding affinity to human LXRbeta-LBD by surface plasmon resonance2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768913Inhibition of human thrombin assessed as inhibition of fibrinogen alpha polymer formation at IC50 after 15 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758942Agonist activity at LXRbeta (unknown origin) expressed in CHOK1 cells assessed as induction of transactivation activity at 100 uM after 24 hrs by luciferase reporter gene assay relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID320801Inhibition of beta amyloid 25-35 fibril formation at 10 uM2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
New polyphenols active on beta-amyloid aggregation.
AID758926Agonist activity at LXR in human THP1 cells assessed as reduction in cellular triglyceride at 100 uM after 24 hrs2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID758940Agonist activity at human LXRalpha-LBD assessed as recruitment of co-activator peptide after 2 hrs by TR-FRET assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768903Inhibition of human thrombin assessed as decrease in platelet aggregation preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1247840Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay2015Journal of medicinal chemistry, Sep-24, Volume: 58, Issue:18
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
AID378691Inhibition of PGHS2 assessed as conversion of arachidonic acid to prostaglandin1999Journal of natural products, Feb, Volume: 62, Issue:2
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries.
AID758925Agonist activity at LXR in human HepG2 cells assessed as reduction in cellular triglyceride at 100 uM after 24 hrs2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID758935Agonist activity at LXR in human HepG2 cells assessed as upregulation of SREBP1C expression at 100 uM after 24 hrs by RT-qPCR analysis relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768921Inhibition of human thrombin assessed as inhibition of fibrinogen alpha-polymer formation at 2.5 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758929Agonist activity at LXR in human THP1 cells assessed as reduction in cellular cholesterol after 24 hrs2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768914Inhibition of human thrombin assessed as inhibition of fibrinogen alpha-polymer formation at IC50 after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID768912Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at IC50 after 30 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758946Agonist activity at LXRalpha (unknown origin) expressed in CHOK1 cells assessed as induction of transactivation activity at 100 uM after 24 hrs by luciferase reporter gene assay relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID758928Agonist activity at LXR in human HepG2 cells assessed as reduction in cellular cholesterol after 24 hrs2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768902Inhibition of human thrombin assessed as decrease in platelet aggregation at 5 uM preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis relative to control2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID378693Antioxidant activity in liposomal model assessed as inhibition of ferrous ion-induced lipid peroxidation at 2 mM1999Journal of natural products, Feb, Volume: 62, Issue:2
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID378690Inhibition of PGHS1 assessed as conversion of arachidonic acid to prostaglandin1999Journal of natural products, Feb, Volume: 62, Issue:2
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries.
AID537631Competitive inhibition of Schistosoma mansoni recombinant NAD+ glycohydrolase expressed in Pichia pastoris by Michaelis-Menten equation analysis2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID768915Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at IC50 after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758927Agonist activity at LXR in human HepG2 cells assessed as reduction in cellular triglyceride after 24 hrs2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768895Inhibition of human thrombin assessed as response unit at 1000 uM by BIAcore analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758943Binding affinity to human LXRalpha-LBD by surface plasmon resonance2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID403347Inhibition of COX1 at 5 uM2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID768926Inhibition of human thrombin assessed as inhibition of fibrinogen polymerization at 5 uM preincubated for 10 mins followed by fibrionogen addition measured for 20 mins2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID403348Inhibition of COX2 at 5 uM2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID456319ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID758947Agonist activity at LXRalpha (unknown origin) expressed in CHOK1 cells assessed as induction of transactivation activity at 50 uM after 24 hrs by luciferase reporter gene assay relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768919Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen Aalpha chains at 2.5 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID537628Inhibition of human recombinant CD38 expressed in Pichia pastoris by continuous fluorometric method2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID758938Induction of LXRalpha transcription in human HepG2 cells at 50 to 100 uM after 24 hrs by RT-qPCR analysis relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID603318Inhibition of human CD38 using 20 uM 1, N6-etheno NAD+ as substrate by continuous fluorimetric method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Flavonoids as inhibitors of human CD38.
AID758930Agonist activity at LXR in human THP1 cells assessed as reduction in cellular triglyceride after 24 hrs2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768923Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at IC50 after 15 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID768917Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at 2.5 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758934Agonist activity at LXR in human HepG2 cells assessed as upregulation of ABCG5 expression at 100 uM after 24 hrs by RT-qPCR analysis relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768893Inhibition of human thrombin assessed as equilibrium association constant at 50 to 1000 uM by BIAcore analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID758936Agonist activity at LXR in human HepG2 cells assessed as upregulation of ABCA1 expression at 100 uM after 24 hrs by RT-qPCR analysis relative to control2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID758939Agonist activity at human LXRbeta-LBD assessed as recruitment of co-activator peptide after 2 hrs by TR-FRET assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
AID768911Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen Aalpha chains at IC50 after 30 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID537627Inhibition of Schistosoma mansoni recombinant NAD+ glycohydrolase expressed in Pichia pastoris by continuous fluorometric method2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID768924Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at 2.5 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID474220Cytotoxicity against human HMC1 cells assessed induction of morphological changes at 50 uM2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
New inhibitors for expression of IgE receptor on human mast cell.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (376)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (0.80)18.7374
1990's9 (2.39)18.2507
2000's60 (15.96)29.6817
2010's191 (50.80)24.3611
2020's113 (30.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.73 (24.57)
Research Supply Index5.97 (2.92)
Research Growth Index5.66 (4.65)
Search Engine Demand Index123.88 (26.88)
Search Engine Supply Index2.53 (0.95)

This Compound (59.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.26%)5.53%
Reviews14 (3.61%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other373 (96.13%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]